Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00456014 · ClinicalTrials.gov registry record · NA

Pre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant Treatment

A NA study of Depression, sponsored by New York State Psychiatric Institute.

Completed
Registry status
NA
Development phase
37
Enrollment target
1
Study location

NCT00456014 is a NA study of Depression that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 37 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00456014, a NA study of Depression, has completed, sponsored by New York State Psychiatric Institute.

COMPLETED
Registry status
NA
Development phase
37 participants
Enrollment target
1
Study location

Study Summary

This study will use pre-treatment positron emission topography and functional magnetic resonance imaging scans of the brain to predict the most effective antidepressant treatment for people with major depressive disorder.

Conditions Studied

Depression

Interventions

  • DRUG Escitalopram
  • DRUG Desipramine

Study Locations (1)

New York

  • Columbia University/New York State Psychiatric Institute - New York

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2006-09
Est. Completion 2012-05
Phase NA

Sponsor

New York State Psychiatric Institute

364 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00456014

The ClinicalTrials.gov registry entry for NCT00456014 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (95% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Escitalopram is the first listed.

NCT00456014 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00456014 about?

NCT00456014 is a clinical study titled "Pre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant Treatment". This study will use pre-treatment positron emission topography and functional magnetic resonance imaging scans of the brain to predict the most effective antidepressant treatment for people with major depressive disorder.

What is the current status of trial NCT00456014?

This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2006-09. Estimated completion is 2012-05.

What conditions does trial NCT00456014 study?

This clinical trial studies the following conditions: Depression.

What interventions are being tested in trial NCT00456014?

The interventions under investigation include: Escitalopram (DRUG), Desipramine (DRUG).

Who is sponsoring clinical trial NCT00456014?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00456014 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Depression

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.